1. Home
  2. NBIX vs DUOL Comparison

NBIX vs DUOL Comparison

Compare NBIX & DUOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$155.43

Market Cap

14.4B

Sector

Health Care

ML Signal

HOLD

Logo Duolingo Inc.

DUOL

Duolingo Inc.

HOLD

Current Price

$199.63

Market Cap

8.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
DUOL
Founded
1992
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
14.4B
8.8B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
NBIX
DUOL
Price
$155.43
$199.63
Analyst Decision
Strong Buy
Buy
Analyst Count
19
17
Target Price
$173.79
$330.67
AVG Volume (30 Days)
969.9K
2.0M
Earning Date
10-28-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
12.44
338.81
EPS
4.19
8.04
Revenue
$2,682,700,000.00
$964,271,000.00
Revenue This Year
$23.76
$40.50
Revenue Next Year
$18.01
$22.65
P/E Ratio
$37.10
$24.86
Revenue Growth
19.61
39.86
52 Week Low
$84.23
$166.27
52 Week High
$157.67
$544.93

Technical Indicators

Market Signals
Indicator
NBIX
DUOL
Relative Strength Index (RSI) 64.81 44.78
Support Level $150.26 $181.20
Resistance Level $154.35 $194.20
Average True Range (ATR) 4.16 8.61
MACD 1.07 6.46
Stochastic Oscillator 93.25 93.92

Price Performance

Historical Comparison
NBIX
DUOL

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

About DUOL Duolingo Inc.

Duolingo Inc is a technology company that develops a mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test, and In-App Purchases.

Share on Social Networks: